Stored Cross-Site Scripting in IBM Tivoli Application Dependency Discovery Manager
CVE-2025-23227

5.4MEDIUM

Key Information:

Vendor

IBM
Status
Tivoli Application Dependency Discovery Manager
Vendor
CVE Published:
23 January 2025

What is CVE-2025-23227?

The IBM Tivoli Application Dependency Discovery Manager versions 7.3.0.0 through 7.3.0.11 are susceptible to a stored cross-site scripting vulnerability. This security flaw enables authenticated users to insert arbitrary JavaScript code into the web interface. Such an action could compromise user sessions and potentially lead to the unauthorized disclosure of sensitive information, including credentials, while users operate in a trusted environment.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Tivoli Application Dependency Discovery Manager 7.3.0.0 <= 7.3.0.11

References

https://www.ibm.com/support/pages/node/7181334
vendor-advisory

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.